o Preliminary Proxy
Statement
|
o Confidential, for
Use of the Commission Only (as Permitted by Rule 14a-6(e)
(2))
|
|
|
x Definitive Proxy
Statement
|
|
|
|
o Definitive
Additional Materials
|
|
|
|
o Soliciting
Material Pursuant to Rule 14a-11(c) or Rule
14a-12
|
Re:
|
Notice
of Annual Meeting and Proxy
Statement
|
|
1.
|
Elect
Bovie’s Board of Directors;
|
|
2.
|
Ratify
the selection of Bovie’s independent auditors for 2009;
and
|
Page
|
|
ABOUT
THE ANNUAL MEETING
|
3
|
ANNUAL
REPORT
|
5
|
STOCK
OWNERSHIP
|
5
|
BOARD
OF DIRECTORS
|
5
|
CURRENT
DIRECTORS AND NOMINEES
|
6
|
MEETINGS
OF THE BOARD OF DIRECTORS
|
8
|
DIRECTORS'
COMPENSATION
|
8
|
EXECUTIVE
COMPENSATION
|
8
|
BENEFICIAL
OWNERSHIP OF SECURITIES
|
13
|
SECTION
16 (a) REPORTING COMPLIANCE
|
15
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
|
15
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
|
16
|
OTHER
BUSINESS
|
17
|
PROPOSAL
ONE: ELECTION OF DIRECTORS
|
18
|
PROPOSAL
TWO: RATIFACTION OF SELECTION OF AUDITORS
|
19
|
(a)
|
How
may I vote my shares in person at the
meeting?
|
(b)
|
How can I vote my
shares without attending the
meeting?
|
(a)
|
Can a shareholder
change his vote?
|
(b)
|
How can I change my
vote after I return my proxy
card?
|
|
§
|
to
allow the election of an inspector appointed for our
Annual Meeting to certify the results of
the vote;
|
|
§
|
as
necessary to
meet applicable legal requirements, including the
pursuit or defense of a
judicial action;
|
|
§
|
where
we conclude in good faith that a bona fide dispute exists as to
the authenticity of one or more proxies, ballots, or
votes, or as to the accuracy of the tabulation of such proxies, ballots,
or votes;
|
|
§
|
where
a stockholder expressly requests disclosure or
has made a written comment on a
proxy;
|
|
§
|
where contacting stockholders
by us is necessary to obtain a quorum, the names of stockholders who have
or have not voted (but not how they voted) may be disclosed to us by the
Inspector of Election appointed for the Annual
Meeting;
|
|
§
|
aggregate vote totals
may be disclosed to us from time to time and
publicly announced at the meeting
of stockholders at which they are relevant; and in
the event of any solicitation of proxies with respect
to any of our securities by
a person other than us of which
solicitation we have actual notice.
|
Name
|
Position
|
Director
Since
|
||
Andrew
Makrides
|
Chairman
of the Board,
|
December,
1982
|
||
President,
CEO, Director
|
||||
Moshe
Citronowicz
|
Executive
Vice-President
|
|||
Chief
Operating Officer
|
—
|
|||
J.
Robert Saron
|
Director
and President of
|
August,
1994
|
||
Aaron
Medical Industries, Inc.
|
||||
Gary
Pickett
|
Principal
Accounting Officer (CFO)
|
—
|
||
George
W. Kromer, Jr.
|
Director
|
October,
1995
|
||
Michael
Norman
|
Director
|
August,
2004
|
||
Steve
Livneh
|
Director
|
April,
2008
|
||
Steven
MacLaren
|
Director
|
April,
2008
|
||
August
Lentricchia
|
Director
|
October,
2007
|
||
Peter
Pardoll
|
Director
|
April,
2009
|
||
Gregory
A. Konesky
|
Director
|
November,
2009
|
Name
And
Principal
Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-
Equity
Incentive
Plan
Compensa-tion
Earnings
($)
|
Change
in
Pension
Value
and
Nonquali-fied
Deferred
compen-sation
Earnings
($)
|
All
Other
Compen-Sation
($)
|
Total
($)
|
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i)
|
(j)
|
Andrew
Makrides
President,
CEO, Chairman of the Board
|
2008
2007
2006
|
$208,598
$195,452
$217,358*(1)
|
$3,870
$3,685
$3,685
|
0
0
0
|
0
0
0
|
0
0
0
|
0
0
0
|
$20,553(8)
$21,770(6)
$19,646(7)
|
$223,022
$220,907
$240,689
|
Gary
D.Pickett
CFO,Treasurer,
Secretary
|
2008
2007
2006
|
$104,083
$94,457
$66,442*(A)(4)
|
$1,961
$1,904
$1,731
|
0
0
0
|
0
88,200*(5)
0
|
0
0
0
|
0
0
0
|
$3,316(19)
$3,097(9)
$1,488(10)
|
$109,360
$187,658
$ 69,661
|
J.
Robert Saron
President
Aaron
Medical
and
Director
|
2008
2007
2006
|
$295,650
$276,680
$281,109*(2)
|
$5,480
$5,218
$5,218
|
0
0
0
|
0
0
0
|
0
0
0
|
0
0
0
|
$21,312(13)
$20,413(11)
$16,201(12)
|
$322,442
$302,311
$302,528
|
Moshe
Citronowicz
Vice
President
Chief
Operating
Officer
|
2008
2007
2006
|
$213,197
$203,349
$242,947*(3)
|
$4,026
$3,834
$3,834
|
0
0
0
|
0
0
0
|
0
0
0
|
0
0
0
|
$21,055(16)
$20,109(14)
$18,506(15)
|
$238,278
$227,292
$265,287
|
Steve
Livneh
President
Bovie
Canada
|
2008
2007
2006
|
$164,959
$174,155
$
36,060*(B)
|
$2,747
$3,523
$2,885
|
0
0
0
|
0
0
0
|
0
0
0
|
0
0
0
|
$6,575(20)
$12,664(17)
$1,750(18)
|
$174,281
$190,342
$40,695
|
|
(a)
|
Upon
the death of the Executive, the Executive’s estate shall be paid the basic
annual compensation due the Employee pro-rated through the date of
death.
|
|
(b)
|
By
the resignation of the Executive at any time upon at least thirty (30)
days prior written notice to Bovie in which case Bovie shall be obligated
to pay the Employee the basic annual compensation due him pro-rated to the
effective date of termination,
|
|
(c)
|
By
Bovie, for cause if during the term of the Employment Agreement the
Employee violates the non-competition provisions of his employment
agreement, or is found guilty in a court of law of any crime of moral
turpitude.
|
|
(d)
|
By
Bovie, without cause, with the majority approval of the Board of
Directors, at any time upon at least thirty (30) days prior written notice
to the Executive. In this case Bovie shall be obligated to pay the
Executive compensation in effect at such time, including all bonuses,
accrued or prorated, and expenses up to the date of termination.
Thereafter, for the period remaining under the contract, Bovie shall pay
the Executive the salary in effect at the time of termination payable
weekly until the end of their
contract.
|
|
(e)
|
If
Bovie fails to meet its obligations to the Executive on a timely basis, or
if there is a change in the control of Bovie, the Executive may elect to
terminate his employment agreement. Upon any such termination or breach of
any of its obligations under the Employment Agreement, Bovie shall pay the
Executive a lump sum severance equal to three times the annual salary and
bonus in effect the month preceding such termination or breach as well as
any other sums which may be due under the terms of the Employment
Agreement up to the date of
termination.
|
Option
Awards
|
||||||||
Name
|
Number
of Shares
Acquired on Exercise
|
Value Realized Upon
Exercise ($) (1)
|
||||||
Andrew
Makrides
|
390,000 | $ | 2,313,700 | |||||
J.
Robert Saron
|
195,000 | $ | 1,156,850 | |||||
Moshe
Citronowicz
|
390,000 | $ | 2,313,700 | |||||
Steve
Livneh
|
-- | -- | ||||||
Gary
Pickett
|
-- | -- |
(1)
|
The
value realized equals the excess of the fair market value of our common
stock on the exercise date over the option exercise price, multiplied by
the number of options
exercised.
|
Outstanding
Equity Awards at 12/31/08
|
|||||||||||||
Name
|
# of Securities
Underlying
Unexercised
Options
(# Exercisable)
|
#
of Securities
Underlying
Unexercised
Options
(# Unexercisable)
(*)
|
Option
Exercise
Price
($/sh)
|
Option
Expiration
Date
|
|||||||||
Andrew
Makrides
|
25,000 | -- | 3.25 |
9/29/2013
|
|||||||||
25,000 | -- | 2.13 |
9/23/2014
|
||||||||||
25,000 | -- | 2.25 |
5/5/2015
|
||||||||||
J.
Robert Saron
|
12,500 | -- | 3.25 |
9/29/2013
|
|||||||||
12,500 | -- | 2.13 |
9/23/2014
|
||||||||||
12,500 | -- | 2.25 |
5/5/2015
|
||||||||||
Moshe
Citronowicz
|
25,000 | -- | 3.25 |
9/29/2013
|
|||||||||
25,000 | -- | 2.13 |
9/23/2014
|
||||||||||
25,000 | -- | 2.25 |
5/5/2015
|
||||||||||
Gary
Pickett
|
20,000 | -- | 8.66 |
1/12/2017
|
|||||||||
5,000 | -- | 7.10 |
3/29/2017
|
||||||||||
Steve
Livneh (1)
|
100,000 | -- | 3.26 |
1/1/2016
|
Name
|
Fees
Earned
Or
Paid
In
Cash
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive
Plan
Compensa-tion
($)
|
Change
in Pension
Value
and
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compensa-
tion
($)
|
Total
($)
|
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
Brian
Madden
|
0
|
0
|
$32,250*
(1)
|
0
|
0
|
0
|
$32,250
|
Michael
Norman
|
0
|
0
|
$32,250*
(2)
|
0
|
0
|
0
|
$32,250
|
Randy
Rossi
|
0
|
0
|
$28,200*
(3)
|
0
|
0
|
0
|
$28,200
|
Steven
MacLaren
|
0
|
0
|
$21,150*
(4)
|
0
|
0
|
0
|
$21,150
|
Number
of Shares
|
||||||||
|
Nature
of
|
Percentage
of
|
||||||
Name
and Address
|
Title
|
Owned
(i)
|
Ownership
|
Ownership
(i)
|
||||
The
Frost National Bank
|
Common
|
300,000
|
Beneficial
|
1.8%
|
||||
FBO
Renaissance
|
||||||||
US
Growth Investment
|
||||||||
Trust
PLC.
|
||||||||
Trust
no. W00740100
|
||||||||
The
Frost National Bank
|
Common
|
1,000,000
|
Beneficial
|
5.9%
|
||||
FBO,
BFS US Special
|
||||||||
Opportunities
Trust PLC.
|
||||||||
Trust
no. W00118000
|
||||||||
Directors
and Officers
|
||||||||
Andrew
Makrides
734
Walt Whitman Road
Melville,
NY 11746
|
Common
|
779,213(ii)
|
Beneficial
|
4.6%
|
||||
George
Kromer
P.O.
Box 188
Farmingville,
NY 11738
|
Common
|
357,008(iii)
|
Beneficial
|
2.1%
|
J.
Robert Saron
7100
30th
Avenue North
St.
Petersburg, FL 33710
|
Common
|
484,819(iv)
|
Beneficial
|
2.9%
|
||||
Brian
Madden
300
Garden City Plaza
Garden
City, NY 11530
|
Common
|
115,500
(vi)
|
Beneficial
|
0.7%
|
||||
Mike
Norman
|
Common
|
85,000(vii)
|
Beneficial
|
0.5%
|
||||
410
Jericho Tpke.
|
||||||||
Jericho,
NY
|
||||||||
Randy
Rossi
|
Common
|
55,000(viii)
|
Beneficial
|
0.3%
|
||||
2641
Kelliwood Circle
|
||||||||
Shreveport,
LA
|
||||||||
Moshe
Citronowicz
7100
30th
Avenue North
St.
Petersburg, FL 33710
|
Common
|
541,504
(v)
|
Beneficial
|
3.2%
|
||||
Gary
Pickett
|
Common
|
25,000
(ix)
|
Beneficial
|
0.2%
|
||||
7100
30th
Avenue North
St.
Petersburg, FL 33710
|
||||||||
Steve
Livneh
|
Common
|
300,000
(x)
|
Beneficial
|
1.8%
|
||||
4056
North Services Rd. E.
|
||||||||
Windsor,
Canada
|
||||||||
August
Lentricchia
|
Common
|
9,100
(xi)
|
Beneficial
|
0.1%
|
||||
734
Walt Whitman Road
Melville,
NY 11746
|
||||||||
Steven
MacLaren
|
Common
|
12,500
(xii)
|
Beneficial
|
0.1%
|
||||
7100
30th
Avenue North
St.
Petersburg, FL 33710
|
||||||||
Officers
and Directors as a group (11 Persons)
|
2,764,644(xiii)
|
16.3%
|
|
·
|
Cash
of $350,000; $150,000 of which was paid at inception and $100,000 of which
was paid in two installments of $50,000 in October 2007 and October 2008.
The remaining $100,000 is to be paid in $50,000 installments in October
2009 and October 2010.
|
|
·
|
200,000
shares of our restricted common stock; 80,000 of which vested immediately,
40,000 of which vested in October 2006, 40,000 of which vested in October
2007 and 40,000 of which vested in October
2008
|
|
·
|
80,000
shares upon the receipt of certain FDA marketing
clearances.
|
|
·
|
17,500
shares upon the Company attaining $1,000,000 in net sales of the “Seal and
Cut Product”
|
|
·
|
17,500
shares upon the Company attaining $3,000,000 in net sales of the “Seal and
Cut Product”
|
|
·
|
17,500
shares upon the Company attaining $1,000,000 in net sales of the
“Modullion Product”
|
|
·
|
17,500
shares upon the Company attaining $3,000,000 in net sales of the
“Modullion Product”
|
|
·
|
Tip-On-Tube
a disposable tip technology complementary to Bovie’s previously acquired
and announced Modular Ergonomic Grip (MEG) forceps. Bovie
acquired the MEG technology in January
2006.
|
|
·
|
A
new surgical handle platform called the Polarian. The Polarian handle
supports a plurality of electrical and mechanical modes to be used in
conjunction with disposable, Seal-N-Cut bipolar cartridges. This is an
advanced entrant into the growing vessel and tissue sealing and cutting
market.
|
2008
|
2007
|
|||||||
Audit
Fees (1)
|
$ | 162,651 | $ | 133,652 | ||||
Non-Audit
Fees:
|
||||||||
Related
Fees(2)
|
52,935 | -- | ||||||
Tax
Fees(3)
|
5,689 | 4,400 | ||||||
All
other Fees(4)
|
12,882 | 15,206 | ||||||
Total
Fees billed
|
$ | 234,157 | $ | 153,258 |